Advertisement

Laparoscopic approach for left-sided T4 colon cancer is a safe and feasible procedure, compared to open surgery

  • Jung Ho Park
  • Hyoung-Chul ParkEmail author
  • Sung Chan Park
  • Dae Kyung Sohn
  • Jae Hwan Oh
  • Sung-Bum Kang
  • Seung Chul Heo
  • Min Jung Kim
  • Ji Won Park
  • Seung-Yong Jeong
  • Kyu Joo Park
  • On behalf of the SEoul COlorectal research Group (SECOG)
Article
  • 124 Downloads

Abstract

Background

A laparoscopic approach can be attempted for pathologic T4 (pT4) colon cancer. Our aim was to evaluate the clinico-oncologic outcomes following laparoscopic versus open surgery for right and left-sided pT4 colon cancer.

Methods

From a multicentric collaborative database, we enrolled 245 patients with right-sided colon cancer (RCC, 128 laparoscopy and 117 open) and 338 with left-sided colon cancer (LCC, 176 laparoscopy and 162 open). All patients underwent intended curative surgery for histologically proven T4 adenocarcinoma, between 2004 and 2013. The primary end-point of our analysis was the oncologic outcome, including the 5-year disease-free survival (5 year-DFS) and the 5-year overall survival (5 year-OS). The secondary end-points included the R0 resection rate and postoperative complications.

Results

Our study group included 224 T4N0 and 359 T4N+ tumors. The median follow-up was 53 months. For patients with RCC, the rate of postoperative morbidities was lower for the laparoscopy than that for the open surgery group (12.5 vs. 22.2%, p = 0.044). There was no difference in the R0 resection rate (94.5 vs. 96.6%, p = 0.425) between the groups. The 5 year-DFS and 5 year-OS rates were lower for the laparoscopy than that in the open group (48.9% vs. 59.2%, p = 0.093; 60.0% vs. 70.0%, p = 0.284, respectively), but this difference was not statistically significant. Among patients with LCC, there were no differences in the rate of postoperative complication and R0 resection (15.3 vs. 21.0%, p = 0.307; 96.0 vs. 95.7%, p = 0.875, respectively). Both groups had comparable 5 year-DFS and 5 year-OS rates (62.7% vs. 61.1%, p = 0.552; 72.0% vs. 71.8%, p = 0.611, respectively).

Conclusions

Laparoscopic surgery appears to be a safe procedure for patients with pT4 LCC, but requires careful consideration for patients with pT4 RCC.

Keywords

Laparoscopy Oncologic outcomes T4 colon cancer Tumor location 

Notes

Compliance with ethical standards

Disclosures

Jung Ho Park, Hyoung-Chul Park, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Sung-Bum Kang, Seung Chul Heo, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, and Kyu Joo Park have no conflicts of interest or financial ties to disclose.

References

  1. 1.
    Kim IY, Kim BR, Kim YW (2016) The short-term and oncologic outcomes of laparoscopic versus open surgery for T4 colon cancer. Surg Endosc 30:1508–1518CrossRefGoogle Scholar
  2. 2.
    de’Angelis N, Vitali GC, Brunetti F, Wassmer CH, Gagniere C, Puppa G, Tournigand C, Ris F (2016) Laparoscopic vs. open surgery for T4 colon cancer: a propensity score analysis. Int J Colorectal Dis 31:1785–1797CrossRefGoogle Scholar
  3. 3.
    Yang ZF, Wu DQ, Wang JJ, Lv ZJ, Li Y (2018) Short- and long-term outcomes following laparoscopic vs open surgery for pathological T4colorectal cancer: 10 years of experience in a single center. World J Gastroenterol 24:76–86CrossRefGoogle Scholar
  4. 4.
    Leon P, Iovino MG, Giudici F, Sciuto A, de Manzini N, Cuccurullo D, Corcione F (2018) Oncologic outcomes following laparoscopic colon cancer resection for T4 lesions: a case-control analysis of 7-years’ experience. Surg Endosc 32:1133–1140CrossRefGoogle Scholar
  5. 5.
    Wang H, Chen X, Liu H, Mou T, Deng H, Zhao L, Li G (2018) Laparoscopy-assisted colectomy as an oncologically safe alternative for patients with stage T4 colon cancer: a propensity-matched cohort study. BMC Cancer 18:370CrossRefGoogle Scholar
  6. 6.
    Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15:2388–2394CrossRefGoogle Scholar
  7. 7.
    Suttie SA, Shaikh I, Mullen R, Amin AI, Daniel T, Yalamarthi S (2011) Outcome of right- and left-sided colonic and rectal cancer following surgical resection. Colorectal Dis 13:884–889CrossRefGoogle Scholar
  8. 8.
    Park HC, Shin A, Kim BW, Jung KW, Won YJ, Oh JH, Jeong SY, Yu CS, Lee BH (2013) Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry. Ann Coloproctol 29:144–149CrossRefGoogle Scholar
  9. 9.
    Gervaz P, Usel M, Rapiti E, Chappuis P, Neyroud-Kaspar I, Bouchardy C (2016) Right colon cancer: left behind. Eur J Surg Oncol 42:1343–1349CrossRefGoogle Scholar
  10. 10.
    Aoyama T, Kashiwabara K, Oba K, Honda M, Sadahiro S, Hamada C, Maeda H, Mayanagi S, Kanda M, Sakamoto J, Saji S, Yoshikawa T (2017) Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials. Cancer Med 6:2523–2530CrossRefGoogle Scholar
  11. 11.
    Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ (2015) Comparative effectiveness of laparoscopy vs open colectomy among nonmetastatic colon cancer patients: an analysis using the National Cancer Data Base. J Natl Cancer Inst.  https://doi.org/10.1093/jnci/dju491 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Scheidbach H, Garlipp B, Oberländer H, Adolf D, Köckerling F, Lippert H (2011) Conversion in laparoscopic colorectal cancer surgery: impact on short-and long-term outcome. J Laparoendosc Adv Surg Tech A 21:923–927CrossRefGoogle Scholar
  13. 13.
    Clancy C, O’Leary DP, Burke JP, Redmond HP, Coffey JC, Kerin MJ, Myers E (2015) A meta-analysis to determine the oncological implications of conversion in laparoscopic colorectal cancer surgery. Colorectal Dis 17:482–490CrossRefGoogle Scholar
  14. 14.
    Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG (2014) pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd’s local peritoneal involvement revisited. Int J Cancer 135:467–478CrossRefGoogle Scholar
  15. 15.
    Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van Cutsem E, D’Hoore A (2012) HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 23:3123–3129CrossRefGoogle Scholar
  16. 16.
    van Santvoort HC, Braam HJ, Spekreijse KR, Koning NR, de Bruin PC, de Vries Reilingh TS, Boerma D, Smits AB, Wiezer MJ, van Ramshorst B (2014) Peritoneal carcinomatosis in T4 colorectal cancer: occurrence and risk factors. Ann Surg Oncol 21:1686–1691CrossRefGoogle Scholar
  17. 17.
    Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, Endo H, Shiratori Y (2008) Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 23:418–423CrossRefGoogle Scholar
  18. 18.
    Gao XH, Yu GY, Gong HF, Liu LJ, Xu Y, Hao LQ, Liu P, Liu ZH, Bai CG, Zhang W (2017) Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer. Sci Rep 7:7882CrossRefGoogle Scholar
  19. 19.
    Stintzing S, Tejpar S, Gibbs P, Thiebach L, Lenz HJ (2017) Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes. Eur J Cancer 84:69–80CrossRefGoogle Scholar
  20. 20.
    Berntsson J, Svensson MC, Leandersson K, Nodin B, Micke P, Larsson AH, Eberhard J, Jirström K (2017) The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a cohort study. Int J Cancer 141:1654–1666CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Jung Ho Park
    • 1
  • Hyoung-Chul Park
    • 1
    • 2
    Email author
  • Sung Chan Park
    • 2
  • Dae Kyung Sohn
    • 2
  • Jae Hwan Oh
    • 2
  • Sung-Bum Kang
    • 3
  • Seung Chul Heo
    • 4
  • Min Jung Kim
    • 5
  • Ji Won Park
    • 5
  • Seung-Yong Jeong
    • 5
  • Kyu Joo Park
    • 5
  • On behalf of the SEoul COlorectal research Group (SECOG)
  1. 1.Department of SurgeryHallym University College of MedicineAnyangSouth Korea
  2. 2.Center for Colorectal CancerNational Cancer CenterGoyangSouth Korea
  3. 3.Department of SurgerySeoul National University Bundang HospitalSeongnamSouth Korea
  4. 4.Department of SurgerySeoul Metropolitan Government-Seoul National University Boramae Medical CenterSeoulSouth Korea
  5. 5.Department of SurgerySeoul National University College of MedicineSeoulSouth Korea

Personalised recommendations